A new paradigm in cancer treatment – combining the effectiveness of targeted therapy and immunotherapy

A new paradigm in cancer treatment – combining the effectiveness of targeted therapy and immunotherapy

Professor Jeff Evans

Professor Evans is Professor of Translational Cancer Research and Director of the Institute of Cancer Sciences, University of Glasgow. He is also Honorary Consultant in Medical Oncology at the Beatson West of Scotland Cancer Centre, Glasgow, Group Leader (Translational Cancer Therapeutics Laboratory) at the CRUK Beatson Institute, Glasgow, and Lead of the Glasgow Experimental Cancer Medicine Centre (ECMC). His clinical interests are in Upper GI Cancers and Melanoma, and his research interests are in the pre-clinical and clinical development of novel anti-cancer agents including molecular targeted therapies, and he leads the Phase I clinical trials and drug development team in Glasgow.